Fundraising Fox

Respira

Founded 2010 · 10 employees on LinkedIn · 3 known investors

Respira develops inhaled therapeutic products for pulmonary diseases, including a novel dry-powder inhalation device and lead product candidate RT234 for pulmonary arterial hypertension. The company focuses on creating drug-device combination products using advanced particle engineering and formulation technologies.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

JKJohn Kollins
John KollinsinChief Executive Officer

Investors · 3

Cottonwood Technology FundDenver · $1M – $25M
Samsara BioCapitalPalo Alto
Zentynel Frontier InvestmentsreportedSantiago

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 3

by search overlap
Respiramedical13 shared keywordsRespira provided clinical respiratory services, sleep, home medical equipment, and home health care to patients across the Mid-Atlantic Region. The company ceased business operations as of March 9, 2018.
Freespira10 shared keywordsFreespira develops an FDA-indicated medical device combined with clinical support for treating PTSD and panic disorder symptoms at home over 28 days. The solution serves health plans, healthcare providers, and self-insured employers seeking to improve patient outcomes and optimize healthcare resource utilization.
Spyre Therapeutics9 shared keywordsSpyre develops and commercializes treatments for a broad range of diseases focused on improving patient outcomes.

Companies competing with Respira for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

For Monitoring COPD, Asthma, Respira Raises $2.8M for Wearable Devicecopdnewstoday.com · Feb 2022Medtech Respira Labs raises $2.8M in pre-seed round - LatamListlatamlist.com · Feb 2022Lung-health startup Respira Labs inhales $2.8M to help respiration patients breathe easier | TechCrunchtechcrunch.com · Feb 2022Latina-Led Respira Labs Raises $2.8 Million to Revolutionize Respiratory Care for COPD, COVID-19 and Asthma Patientsfinance.yahoo.com · Feb 2022Respira Labs Raises $2.8M in Pre-Seed Fundingfinsmes.com · Feb 2022

Frequently asked questions

What does Respira do?
Respira develops inhaled therapeutic products for pulmonary diseases, including a novel dry-powder inhalation device and lead product candidate RT234 for pulmonary arterial hypertension. The company focuses on creating drug-device combination products using advanced particle engineering and formulation technologies.
Who are Respira's investors?
Respira's investors include Cottonwood Technology Fund, Samsara BioCapital, Zentynel Frontier Investments.